Sinocare Inc.
Jiyun Zheng, PhD, currently serves as Vice President and Board Secretary at Sinocare Inc., where responsibilities include leading global business development and strategic partnerships, alongside acting as Principal Expert in Microbiology and Biocompatibility. Jiyun formulated the biocompatibility management strategy for the company's first Continuous Glucose Monitoring System. Previously, Jiyun was a Senior Research Scientist at HOYA Surgical Optics, focusing on biocompatibility for intraocular lenses. Additional experience includes serving as a Research Fellow at the Mechanobiology Institute and completing a PhD at the National University of Singapore, where the research concentrated on antibody discovery. Jiyun holds a Bachelor's degree in Bioengineering and Biomedical Engineering from the same institution. Research expertise encompasses antibody engineering, phage display, and affinity purification.
This person is not in any teams
This person is not in any offices
Sinocare Inc.
As a high-tech company, Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing of POCT products since its establishment in Aug,2002. Sinocare focuses intensively and extensively on the R&D of products and innovation of technology, casting our look into the future, to deliver significant benefits for people pursuing healthy living. In March, 2012, Sinocare Inc. was listed on Shenzhen Stock Exchange, abbreviated as "Sinocare" with stock code 300298. We passed ISO13485 and our products were certified by EU CE. The company's Sinocare glucometer series and its test strips has won an universal recognition from a large number of consumers thanks to its accuracy, simplicity and affordability. The product is not only popular in China, but also exports in large scale. Observing the values of “equality, honesty, innovation and excellence”, Sinocare conducts continuous innovation and establishes "portable laboratory" based on POCT product. The company aims at providing quality product and service for China’s chronic disease management, help chronic disease patients improve living quality and reduce the burden of social medical care system.